Insignificant disease among men with intermediate-risk prostate cancer

被引：0
|
作者：
Sung Kyu Hong
Emily Vertosick
Daniel D. Sjoberg
Peter T. Scardino
James A. Eastham
机构：
[1] Memorial Sloan-Kettering Cancer Center,Urology Service, Department of Surgery
[2] Seoul National University Bundang Hospital,Department of Urology
[3] Memorial Sloan-Kettering Cancer Center,Department of Epidemiology and Biostatistics
[4] Cornell University,Department of Urology, Weill Cornell Medical College
来源：
World Journal of Urology | 2014年 / 32卷
关键词：
Prostate; Prostatic neoplasms; Insignificant; Intermediate risk; Prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1417 / 1421
页数：4
相关论文
共 50 条
  • [31] Current insights on PSMA PET/CT in intermediate-risk prostate cancer: a literature review
    Guglielmo, Priscilla
    Buffi, Nicolo
    Porreca, Angelo
    Setti, Lucia
    Arico, Demetrio
    Muraglia, Lorenzo
    Evangelista, Laura
    ANNALS OF NUCLEAR MEDICINE, 2025, 39 (03) : 247 - 254
  • [32] Active surveillance in favorable intermediate-risk prostate cancer: A single-center experience
    Bandelier, Q.
    Bastide, C.
    Charvet, A. -L
    Leclercq, L.
    Gondran-Tellier, B.
    Campagna, J.
    Long-Depaquit, T.
    Daniel, L.
    Rossi, D.
    Lechevallier, E.
    Baboudjian, M.
    FRENCH JOURNAL OF UROLOGY, 2024, 34 (01):
  • [33] Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer
    Butler, Santino S.
    Mahal, Brandon A.
    Lamba, Nayan
    Mossanen, Matthew
    Martin, Neil E.
    Mouw, Kent W.
    Nguyen, Paul L.
    Muralidhar, Vinayak
    CANCER, 2019, 125 (18) : 3164 - 3171
  • [34] Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
    Hoeh, Benedikt
    Flammia, Rocco
    Hohenhorst, Lukas
    Sorce, Gabriele
    Chierigo, Francesco
    Tian, Zhe
    Saad, Fred
    Gallucci, Michele
    Briganti, Alberto
    Terrone, Carlo
    Shariat, Shahrokh F.
    Graefen, Markus
    Tilki, Derya
    Kluth, Luis A.
    Mandel, Philipp
    Chun, Felix K. H.
    Karakiewicz, Pierre, I
    PROSTATE INTERNATIONAL, 2022, 10 (01) : 21 - 27
  • [35] Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men With Low or Intermediate Risk Disease
    Arvold, Nils D.
    Chen, Ming-Hui
    Moul, Judd W.
    Moran, Brian J.
    Dosoretz, Daniel E.
    Banez, Lionel L.
    Katin, Michael J.
    Braccioforte, Michelle H.
    D'Amico, Anthony V.
    JOURNAL OF UROLOGY, 2011, 186 (01): : 91 - 96
  • [36] Survival after radiotherapy vs. radical prostatectomy for unfavorable intermediate-risk prostate cancer
    Sebastian, Nikhil T.
    McElroy, Joseph P.
    Martin, Douglas D.
    Sundi, Debasish
    Diaz, Dayssy Alexandra
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (11) : 813.e11 - 813.e19
  • [37] Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach
    Michael Baboudjian
    Alberto Breda
    Thierry Roumeguère
    Alessandro Uleri
    Jean-Baptiste Roche
    Alae Touzani
    Vito Lacetera
    Jean-Baptiste Beauval
    Romain Diamand
    Guiseppe Simone
    Olivier Windisch
    Daniel Benamran
    Alexandre Fourcade
    Gaelle Fiard
    Camille Durand-Labrunie
    Mathieu Roumiguié
    Francesco Sanguedolce
    Marco Oderda
    Eric Barret
    Gaëlle Fromont
    Charles Dariane
    Anne-Laure Charvet
    Bastien Gondran-Tellier
    Cyrille Bastide
    Eric Lechevallier
    Joan Palou
    Alain Ruffion
    Roderick C. N. Van Der Bergh
    Alexandre Peltier
    Guillaume Ploussard
    World Journal of Urology, 2023, 41 : 1301 - 1308
  • [38] Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts
    Merrick, Gregory S.
    Butler, Wayne M.
    Galbreath, Robert W.
    Fiano, Ryan
    Adamovich, Edward
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2015, 7 (06) : 430 - 436
  • [39] Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach
    Baboudjian, Michael
    Breda, Alberto
    Roumeguere, Thierry
    Uleri, Alessandro
    Roche, Jean-Baptiste
    Touzani, Alae
    Lacetera, Vito
    Beauval, Jean-Baptiste
    Diamand, Romain
    Simone, Guiseppe
    Windisch, Olivier
    Benamran, Daniel
    Fourcade, Alexandre
    Fiard, Gaelle
    Durand-Labrunie, Camille
    Roumiguie, Mathieu
    Sanguedolce, Francesco
    Oderda, Marco
    Barret, Eric
    Fromont, Gaelle
    Dariane, Charles
    Charvet, Anne-Laure
    Gondran-Tellier, Bastien
    Bastide, Cyrille
    Lechevallier, Eric
    Palou, Joan
    Ruffion, Alain
    Van der Bergh, Roderick C. N.
    Peltier, Alexandre
    Ploussard, Guillaume
    WORLD JOURNAL OF UROLOGY, 2023, 41 (05) : 1301 - 1308
  • [40] Adverse Disease Features in Gleason Score 3+4 "Favorable Intermediate-Risk'' Prostate Cancer: Implications for Active Surveillance
    Morlacco, Alessandro
    Cheville, John C.
    Rangel, Laureano J.
    Gearman, Derek J.
    Karnes, R. Jeffrey
    EUROPEAN UROLOGY, 2017, 72 (03) : 442 - 447
12345